Back to Search
Start Over
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment.
- Source :
- Dermatology & Therapy; Aug2024, Vol. 14 Issue 8, p2249-2260, 12p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 21938210
- Volume :
- 14
- Issue :
- 8
- Database :
- Supplemental Index
- Journal :
- Dermatology & Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 179087113
- Full Text :
- https://doi.org/10.1007/s13555-024-01226-9